Skip to main content
Erschienen in: Lung 1/2019

30.11.2018 | PLEURAL DISEASE

Pleural Effusions in Diffuse Large B-Cell Lymphoma: Clinical and Prognostic Significance

verfasst von: José M. Porcel, Irene Cuadrat, Tomás García-Cerecedo, Marina Pardina, Silvia Bielsa

Erschienen in: Lung | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pleural effusion (PEs) may complicate diffuse large B-cell lymphomas (DLBCL). However, their real prevalence and prognostic significance have seldom been approached systematically.

Methods

Retrospective single-center evaluation of consecutive patients with DLBCL was conducted. Baseline characteristics, PEs on CT imaging, pleural fluid analyses, and outcome until death or censoring date were collected.

Results

Of 185 DLBCL patients, 55 (30%) had PEs, of which 27 (49%) were analyzed. Most tapped PEs were malignant (n = 24) and cytological and/or flow cytometric analyses provided the diagnosis in about 70% of the cases. Malignant PEs were exudates with adenosine deaminase levels > 35 U/L in 35% of the cases. More than one-third of lymphomatous PEs required definitive pleural procedures for symptomatic relief. PEs greater than 200 mL on CT scans were an independent predictor of poor survival in Cox regression modeling (hazard ratio 1.9).

Conclusions

PEs are common in DLBCL and foreshadow a poor prognosis.
Literatur
2.
Zurück zum Zitat Elis A, Blickstein D, Mulchanov I, Manor Y, Radnay J, Shapiro H, Lishner M (1998) Pleural effusion in patients with non-Hodgkin’s lymphoma: a case-controlled study. Cancer 83:1607–1611CrossRefPubMed Elis A, Blickstein D, Mulchanov I, Manor Y, Radnay J, Shapiro H, Lishner M (1998) Pleural effusion in patients with non-Hodgkin’s lymphoma: a case-controlled study. Cancer 83:1607–1611CrossRefPubMed
6.
Zurück zum Zitat Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, Bintcliffe OJ, Boshuizen RC, Fysh ET, Tobin CL, Medford AR, Harvey JE, van den Heuvel MM, Lee YC, Maskell NA (2014) Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax 69:1098–1104. https://doi.org/10.1136/thoraxjnl-2014-205285 CrossRefPubMed Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, Bintcliffe OJ, Boshuizen RC, Fysh ET, Tobin CL, Medford AR, Harvey JE, van den Heuvel MM, Lee YC, Maskell NA (2014) Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax 69:1098–1104. https://​doi.​org/​10.​1136/​thoraxjnl-2014-205285 CrossRefPubMed
10.
Zurück zum Zitat Ahmed S, Shahid RK, Rimawi R, Siddiqui AK, Rossoff L, Sison CP, Steinberg H, Rai KR (2005) Malignant pleural effusions in lymphoproliferative disorders. Leuk Lymphoma 46:1039–1044CrossRefPubMed Ahmed S, Shahid RK, Rimawi R, Siddiqui AK, Rossoff L, Sison CP, Steinberg H, Rai KR (2005) Malignant pleural effusions in lymphoproliferative disorders. Leuk Lymphoma 46:1039–1044CrossRefPubMed
17.
Zurück zum Zitat Bairey O, Bar-Natan M, Shpilberg O (2013) Early death in patients diagnosed with non-Hodgkin’s lymphoma. Ann Hematol 92:345–350CrossRefPubMed Bairey O, Bar-Natan M, Shpilberg O (2013) Early death in patients diagnosed with non-Hodgkin’s lymphoma. Ann Hematol 92:345–350CrossRefPubMed
Metadaten
Titel
Pleural Effusions in Diffuse Large B-Cell Lymphoma: Clinical and Prognostic Significance
verfasst von
José M. Porcel
Irene Cuadrat
Tomás García-Cerecedo
Marina Pardina
Silvia Bielsa
Publikationsdatum
30.11.2018
Verlag
Springer US
Erschienen in
Lung / Ausgabe 1/2019
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-018-0182-y

Weitere Artikel der Ausgabe 1/2019

Lung 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.